Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain

Journal of Infection

Volumn 54, Issue 1, 2007, Pages 65-74

  Jiménez García, Rodrigo ^a   Ariñez Fernandez, Maria C ^a   Hernández Barrera, Valentín ^a   Garcia Carballo, Marta M ^a   de Miguel, Ángel Gil ^a   Carrasco Garrido, Pilar ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

COPD; Influenza; Streptococcus pneumoniae; Vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; DEPENDENT VARIABLE; DISEASE COURSE; DISEASE DURATION; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INDEPENDENT VARIABLE; INFLUENZA; INFLUENZA VACCINATION; INTERVIEW; LIFESTYLE; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; SMOKING; SPAIN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERVIEWS; LIFE STYLE; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIAL CLASS; SPAIN; TIME FACTORS;

EID: 33845582678     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.11.020     Document Type: Article

References (60)

1. Harper S.A. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 53 (2004) 1-40
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46 RR-8 (1997) 1-24
3. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., and Couch R.B. Impact of Respiratory Virus Infections on Persons With Chronic Underlying Conditions. JAMA 283 4 (2000) 499-505
4. Mannino D.M. COPD*: Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity. Chest 121 90050 (2002) 121S-126S
5. Rennard S., Decramer M., Calverley P.M.A., Pride N.B., Soriano J.B., Vermeire P.A., et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 20 4 (2002) 799-805
6. Pena V.S., Miravitlles M., Gabriel R., Jimenez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographic Variations in Prevalence and Underdiagnosis of COPD: Results of the IBERPOC Multicentre Epidemiological Study. Chest 118 4 (2000) 981-989
7. Miravitlles M., Mayordomo C., Artes M., Sanchez-Agudo L., Nicolau F., and Segu J.L. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitacion Obstructiva al Flujo Aéreo. Respir Med 93 3 (1999) 173-179
8. Seemungal T.A., Donaldson G.C., Bhowmik A., Jeffries D.J., and Wedzicha J.A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 5 (2000) 1608-1613
9. Barbera J.A., Peces-Barba G., Agusti A.G., Izquierdo J.L., Monso E., Montemayor T., et al. [Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease]. Arch Bronconeumol 37 6 (2001) 297-316
10. Sethi S., Evans N., Grant B.J., and Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347 7 (2002) 465-471
11. Nuorti J.P., Butler J.C., Farley M.M., Harrison L.H., McGeer A., Kolczak M.S., et al. Cigarette Smoking and Invasive Pneumococcal Disease. N Engl J Med 342 10 (2000) 681-689
12. Wongsurakiat P., Maranetra K.N., Wasi C., Kositanont U., Dejsomritrutai W., and Charoenratanakul S. Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination: A Randomized Controlled Study. Chest 125 6 (2004) 2011-2020
13. Poole P.J., Chacko E., Wood-Baker R.W., and Cates C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2000) (4).CD002733
14. Nichol K.L., Baken L., and Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130 5 (1999) 397-403
15. Hedlund J., Christenson B., Lundbergh P., and Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 21 25-26 (2003) 3906-3911
16. Mangtani P., Cumberland P., Hodgson C.R., Roberts J.A., Cutts F.T., and Hall A.J. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United kingdom general practice research database. J Infect Dis 190 1 (2004) 1-10
17. Koivula I., Sten M., Leinonen M., and Makela P.P.H. Clinical Efficacy of Pneumococcal Vaccine in the Elderly: A Randomized, Single-Blind Population-Based Trial. The American Journal of Medicine 103 4 (1997) 281-290
18. Moore R.A., Wiffen P.J., and Lipsky B.A. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract 1 1 (2000) 1
19. Cornu C., Yzebe D., Leophonte P., Gaillat J., Boissel J.P., and Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 19 32 (2001) 4780-4790
20. Watson L., Wilson B.J., and Waugh N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 20 17-18 (2002) 2166-2173
21. WHO position paper. Pneumococcal vaccines. Weekly epidemiological record 14 (2003) 110-119
22. Generalidad de Cataluña. Departamento de Sanidad y Seguridad Social. Plan de Salud de Cataluña (1999-2001) Barcelona 2000
23. Petersen R.L., Saag K., Wallace R.B., and Doebbeling B.N. Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study. Med Care 37 5 (1999) 502-509
24. CDC. Influenza and pneumococcal vaccination levels among persons aged > or=65 years-United States 2001. MMWR Morb Mortal Wkly Rep 51 45 (2002) 1019-1024
25. Honkanen P.O., Keistinen T., and Kivela S.L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 15 3 (1997) 317-320
26. Christenson B., and Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 129 3 (2002) 515-524
27. Opstelten W., Hak E., Verheij T.J., and van Essen G.A. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. Am J Med 111 6 (2001) 474-479
28. Guerin N. Assessing immunization coverage: how and why?. Vaccine 16 Suppl (1998) S81-S83
29. LeBaron C.W., Chaney M., Baughman A.L., Dini E.F., Maes E., Dietz V., et al. Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA 277 8 (1997) 631-635
30. Kamal K.M., Madhavan S.S., and Amonkar M.M. Determinants of adult influenza and pneumonia immunization rates. J Am Pharm Assoc (Wash DC) 43 3 (2003) 403-411
31. Kroneman M., Paget W.J., and van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill 8 6 (2003) 130-138
32. Chapman G.B., and Coups E.J. Predictors of influenza vaccine acceptance among healthy adults. Prev Med 29 4 (1999) 249-262
33. Garcia MM, Carrasco P, Jimenez R, Martin A, Gobartt E, Gil A. Estudio epidemiológico para valorar la calidad de vida y el consumo de recursos sanitarios en los pacientes con enfermedad pulmonar obstructiva crónica (EPIDEPOC). Metodología y resultados iniciales. MedicinaGeneral 67:485-490.
34. Jimenez R., Larrauri A., Carrasco P., Esteban J., Gomez-Lopez L.I., and Gil A. Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years. Vaccine 21 25-26 (2003) 3550-3555
35. Ministerio de Sanidad y Consumo. España. Vacunación de adultos Documento de la Ponencia de Programas y Registro de Vacunaciones. Publicación del Ministerio de Sanidad y Consumo. Madrid (2004)
36. Singleton J.A., Greby S.M., Wooten K.G., Walker F.J., and Strikas R. Influenza, pneumococcal, and tetanus toxioid vaccination of adults-United States, 1993-7. MMWR CDC Surveill Summ 49 9 (2000) 39-62
37. Peetermans W.E., and Lacante P. Pneumococcal vaccination by general practitioners: an evaluation of current practice. Vaccine 18 7-8 (1999) 612-617
38. Marco J.L., Martin Berra J.C., Corres I.M., Luque D.R., and Zubillaga G.G. Chronic obstructive lung disease in the general population. An epidemiologic study performed in Guipuzcoa. Arch Bronconeumol 34 1 (1998) 23-27
39. Brotons B., Perez J.A., Sanchez-Toril F., Soriano S., Hernandez J., and Belenguer J.L. The prevalence of chronic obstructive pulmonary disease and asthma. A cross-sectional study. Arch Bronconeumol 30 3 (1994) 149-152
40. Krzyzanowski M., and Kauffmann F. The relation of respiratory symptoms and ventilatory function to moderate occupational exposure in a general population. Results from the French PAARC study of 16,000 adults. Int J Epidemiol 17 2 (1988) 397-406
41. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., and Redd S.C. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 51 6 (2002) 1-16
42. Montnemery P., Adelroth E., Heuman K., Johannisson A., Johansson S.A., Lindholm L.H., et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med 92 12 (1998) 1337-1345
43. Centers for Disease Control and Prevention. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or=65 years-United States, 1989-2001. MMWR Morb Mortal Wkly Rep 52 40 (2003) 958-962
44. CDC. Public health and aging: influenza vaccination coverage among adults aged >; or=50 years and pneumococcal vaccination coverage among adults aged >; or=65 years-United States, 2002. MMWR Morb Mortal Wkly Rep 52 41 (2003) 987-992
45. Nichol K.L. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med 105 5 (1998) 385-392
46. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 16 (2003) 1780-1785
47. Generalidad de Cataluña. Departamento de Sanidad y Seguridad Social. Plan de Salud Cataluña 2002-2005: Objectius i intervencions per a la prevenció i control de les malalties transmissibles: Malalties susceptibles de ser previngudes amb vacunacions. Barcelona (2003)
48. Jimenez-Garcia R., Arinez-Fernandez M.C., Garcia-Carballo M., Hernandez-Barrera V., Miguel A.G., and Carrasco-Garrido P. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 23 28 (2005) 3679-3686
49. Sarria-Santamera A., and Timoner J. Influenza vaccination in old adults in Spain. Eur J Public Health 13 2 (2003) 133-137
50. Zhang P., Tao G., and Irwin K.L. Utilization of preventive medical services in the United States: a comparison between rural and urban populations. J Rural Health 16 4 (2000) 349-356
51. Kyaw M.H., Wayne B., Chalmers J., Jones I.G., and Campbell H. Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies. Epidemiol Infect 128 3 (2002) 445-455
52. WHO. Adoption of Global Agenda on Influenza - part II. Weekly epidemiological record 77 (2002) 191-195
53. Shenson D, DiMartino D, Bolen J, Campbell M, Lu PJ, Singleton JA. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine 23[8], 1015-1020. 11-1-2005.
54. Mac D.R., Baken L., Nelson A., and Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 16 3 (1999) 173-177
55. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., and Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 21 13-14 (2003) 1486-1491
56. Rehmet S., Ammon A., Pfaff G., Bocter N., and Petersen L.R. Cross-sectional study on influenza vaccination, Germany, 1999-2000. Emerg Infect Dis 8 12 (2002) 1442-1447
57. Pregliasco F., Sodano L., Mensi C., Selvaggi M.T., Adamo B., D'Argenio P., et al. Influenza vaccination among the elderly in Italy. Bull World Health Organ 77 2 (1999) 127-131
58. Hak E., Hermens R.P., van Essen G.A., Kuyvenhoven M.M., and de Melker R.A. Population-based prevention of influenza in Dutch general practice. Br J Gen Pract 47 419 (1997) 363-366
59. González de A.A. Vacunación antineumocócica en adultos de Cantabria: estrategias de captación y cobertura. Vacunas 5 2p (2004) 38-42
60. Generalidad de Cataluña. Departamento de Sanidad y Seguridad Social. Dirección General de Salud Pública. Guía técnica de la vacuna antigripal. Programa de vacunaciones Campaña 2003/2004. Barcelona 2003.